U.S. Disinfecting Cap Market, by Application (Central Venous Line, Peripheral IV Catheters and Others), and by End User (Hospital and Clinics, Ambulatory/Outpatient Surgical Centers, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 202

U.S. Disinfecting Cap Market, by Application (Central Venous Line, Peripheral IV Catheters and Others), and by End User (Hospital and Clinics, Ambulatory/Outpatient Surgical Centers, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Peripheral IV Catheters (PIVC) are commonly used intravenous devices in hospital settings. PIVC are inserted in small peripheral veins for administration of medications, fluids and/or blood products, and also for blood sampling. Peripheral IV catheter insertion is one of the most common invasive procedures in hospital settings. PIVC are intravenous devices that are used more frequently which can increase risk of infection. As a result, special infection control measures have been applied for such IV devices. In order to avoid contamination risk, most hospitals use PIV bundles, which include disinfecting caps and tips. Central venous line procedures are generally used for hemodynamic monitoring, administration of drugs likely to induce phlebitis, hemodialysis, lack of peripheral venous access, and others. Hence, disinfecting caps are widely used for prevention of central line-associated bloodstream infection (CLABSI).

Market Dynamics

Increasing adoption of inorganic growth strategies such as mergers, agreements and collaborations by key players operating in the market is expected to propel the market growth over the forecast period. For instance, in December 2017, Becton, Dickinson (BD) and Company acquired C. R. Bard, Inc. (Bard). With this acquisition, BD complemented its Interventional segment and medical segment with C.R. Bards' products.

Key features of the study:

This report provides in-depth analysis of the U.S. disinfecting cap market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the U.S. disinfecting cap market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include ICU Medical, C.R. Bard, Becton, Dickinson and Company, 3M, Merit Medical Systems, and other prominent players.
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, Product Type up-gradation, market expansion, and marketing tactics
The U.S. disinfecting cap market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. disinfecting cap market

Detailed Segmentation:

U.S. Disinfecting cap Market, By Application:
Central Venous Line
Peripheral IV Catheters
Others
U.S. Disinfecting cap Market, By End User:
Hospital and Clinics
Ambulatory/Outpatient Surgical Centers
Others
Company Profiles
ICU Medical*
Company Overview
Material Portfolio
Financial Performance
Key Highlights
Market Strategies
R. Bard
Becton, Dickinson and Company
3M
Merit Medical Systems

“*” marked represents similar segmentation in other categories in the respective section.